000 01328 a2200349 4500
005 20250513161007.0
264 0 _c19990323
008 199903s 0 0 eng d
022 _a0143-3636
024 7 _a10.1097/00006231-199812000-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoutroumanidis, M
245 0 0 _aPositron emission tomography in partial epilepsies: the clinical point of view.
_h[electronic resource]
260 _bNuclear medicine communications
_cDec 1998
300 _a1123-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBrain
_xdiagnostic imaging
650 0 4 _aCarbon Radioisotopes
_xpharmacokinetics
650 0 4 _aCerebrovascular Circulation
650 0 4 _aElectroencephalography
650 0 4 _aEpilepsies, Partial
_xdiagnostic imaging
650 0 4 _aFlumazenil
_xpharmacokinetics
650 0 4 _aFluorodeoxyglucose F18
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aRadiopharmaceuticals
_xpharmacokinetics
650 0 4 _aReceptors, GABA-A
_xanalysis
650 0 4 _aTomography, Emission-Computed
700 1 _aBinnie, C D
700 1 _aPanayiotopoulos, C P
773 0 _tNuclear medicine communications
_gvol. 19
_gno. 12
_gp. 1123-6
856 4 0 _uhttps://doi.org/10.1097/00006231-199812000-00003
_zAvailable from publisher's website
999 _c9847583
_d9847583